Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Placebo cream AND Placebo

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    362 result(s) found for: Placebo cream AND Placebo. Displaying page 1 of 19.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2012-004993-25 Sponsor Protocol Number: LIDPR25VER Start Date*: 2013-01-10
    Sponsor Name:Verisfield (UK) Ltd
    Full Title: A multicenter, randomized, patient-blind, investigator-blind, placebo-controlled, crossover study of Lidocaine + Prilocaine/Verisfield (2.5+2.5)% w/w cream and EMLA/AstraZeneca cream, in patients u...
    Medical condition: Pain related to the cannulation of arteriovenous fistula cannulation in haemodialysis patients.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Completed)
    Trial results: View results
    EudraCT Number: 2006-005637-37 Sponsor Protocol Number: ASF-1057-206 Start Date*: 2007-02-28
    Sponsor Name:Astion Danmark A/S
    Full Title: Comparative, placebo controlled, double-blind efficacy and safety study in patients with seborrhoeic dermatitis comparing a topical cream containing 2% Nicotinamide combined with either 0%, 0.5% or...
    Medical condition: Seborrhoeic Dermatitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006756-22 Sponsor Protocol Number: VVS-2.1 Start Date*: 2009-07-09
    Sponsor Name:Neocutis
    Full Title: VVS study: the efficacy and safety of Bio-restorative Skin Cream in the local treatment of vulvar vestibulitis syndrome (VVS) compared with placebo.
    Medical condition: Vulvar vestibulitis syndrome
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2022-001374-60 Sponsor Protocol Number: MOB-02 Start Date*: 2022-07-21
    Sponsor Name:BCN Peptides
    Full Title: A randomized, double blinded, placebo controlled clinical trial to evaluate the antipruritic efficacy of the topical application of PARENTIDE cream in histamine-induced itch in healthy volunteers
    Medical condition: Treatment of pruritus or uticaria
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000775-15 Sponsor Protocol Number: TERBI 06/05 Start Date*: 2006-09-11
    Sponsor Name:PLIVA - ISTRAŽIVANJE I RAZVOJ d.o.o.
    Full Title: Double blind, comparative, randomized, placebo controlled, clinical study of therapeutic equivalence and tolerability of the topical preparation Terbinafine cream 1% (Pliva Croatia) with the medica...
    Medical condition: Uncomplicated Tinea pedis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004220-13 Sponsor Protocol Number: Q-301 Start Date*: 2005-06-08
    Sponsor Name:Q-Develop AB/co Freddie Norberg
    Full Title: Treatment of vulvar vestibulitis by an antioxidant cream: a double-blind, placebo-controlled, parallel group multi-center study
    Medical condition: Vulvar vestibulitis, a recently discovered disease, which mainly affects young women. The symptoms are severe vaginal pain.
    Disease: Version SOC Term Classification Code Term Level
    10047780 PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-006513-33 Sponsor Protocol Number: KETFUN3001 Start Date*: 2007-05-23
    Sponsor Name:Janssen Pharmaceutica NV
    Full Title: A double-blind, randomized, parallel group comparison of Nizoral® cream (F012), ketoconazole 2% cream (F126) and placebo (F000) in the treatment of interdigital Tinea Pedis.
    Medical condition: For the treatment of tinea pedis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-016827-72 Sponsor Protocol Number: GAL-Moa-003 Start Date*: 2010-01-12
    Sponsor Name:Galenica AB
    Full Title: A multicentre, randomized, double-blind, safety and efficacy non-inferiority, intra-individual study, comparing Mometasone furoate Galenica 0.1% cream with Elocon 0.1% cream and placebo in patients...
    Medical condition: Mild to moderate plaque psoriasis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2009-017692-18 Sponsor Protocol Number: 290408BS Start Date*: 2010-02-16
    Sponsor Name:Valderm ApS
    Full Title: A phase IIa, single-center, randomized, observer-blind, placebo- and reference-controlled proof of concept study with intraindividual comparison of treatments to investigate the safety and antipsor...
    Medical condition: Male or female subjects with chronic plaque psoriasis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004648-54 Sponsor Protocol Number: ASF-1057-302 Start Date*: 2007-12-10
    Sponsor Name:Astion Pharma A/S
    Full Title: Efficacy and safety of ASF-1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, multi-centre, double-blind, active comparator (ketoconazole cream 2%) and placebo cont...
    Medical condition: Seborrhoeic dermatitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-003023-10 Sponsor Protocol Number: 03072013 Start Date*: 2013-10-07
    Sponsor Name:Department of Surgery, Herlev Hospital
    Full Title: MELATOX: Pharmacodynamic evaluation of topical use of melatonin as sun protection: a randomized, double blinded, placebo controlled crossover study on healthy volunteers.
    Medical condition: Adverse effects of topical use of melatonin as sun protection.
    Disease: Version SOC Term Classification Code Term Level
    16.0 10018065 - General disorders and administration site conditions 10060933 Adverse event PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000197-20 Sponsor Protocol Number: R013 Start Date*: 2008-11-28
    Sponsor Name:Revotar Biopharmaceuticals AG
    Full Title: Multi-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate the safety and efficacy of Bimosiamose 5% Cream for the treatment of patients with chronic plaque type psoriasis
    Medical condition: chronic plaque-type psoriasis (psoriasis vulgaris)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001062-17 Sponsor Protocol Number: ASF-1096-201/250912BS Start Date*: 2006-11-30
    Sponsor Name:Astion Danmark A/S
    Full Title: Efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with newly developed discoid lupus erythymatosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and doubl...
    Medical condition: Male or female patients with a clinical diagnosis of either Discoid Lupus Erythmatosus or Systemic Lupus Erythmatosus and at least one newly developed, sharply demarcated DLE lesion.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10025138 Lupus erythematosus discoides LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-000552-27 Sponsor Protocol Number: ACO2008-CT-01 Start Date*: 2008-06-11
    Sponsor Name:ACO HUD NORDIC AB
    Full Title: Effect of moisturizing creams on skin barrier function and prevention of Malassezia recurrence in patients with atopic eczema
    Medical condition: Dry skin barrier disorders such as atopic eczema and ichtyosis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000765-78 Sponsor Protocol Number: ROSE-01 Start Date*: 2017-07-18
    Sponsor Name:Medis, d.o.o.
    Full Title: Randomized, Double-blind, Placebo Controlled Clinical Study To Evaluate Analgesic Efficacy of Topically Administered Traditional Herbal Medicinal Product for Relief of Acute Muscular Pain.
    Medical condition: Acute Muscular Pain
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022439-12 Sponsor Protocol Number: ATH008-CLN02 Start Date*: 2011-02-03
    Sponsor Name:Advancell Advanced In Vitro Cell Technologies, S.A
    Full Title: A Phase II Placebo Controlled, Multicenter Study to Investigate the Safety and Efficacy of ATH008 cream in Patients with Palmar-Plantar Erythrodysesthesia Syndrome (PPES) secondary to capecitabine ...
    Medical condition: Palmar-Plantar Erythrodysesthesia Syndrome (PPES)
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10054524 Palmar-plantar erythrodysesthesia syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) ES (Ongoing) DE (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-004899-30 Sponsor Protocol Number: 111187 Start Date*: 2016-12-21
    Sponsor Name:GlaxoSmithKline Research & Development Ltd.
    Full Title: Multi-center, Randomised, Double-blind, Parallel, Placebo Controlled Study Of 0.05% Clobetasone Butyrate Cream in Subjects with Eczema to evaluate the Efficacy and Safety.
    Medical condition: Eczema
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2004-002367-24 Sponsor Protocol Number: PC TA001/04 Start Date*: 2004-10-20
    Sponsor Name:PhotoCure ASA
    Full Title: A blinded, prospective, randomised, placebo-controlled, multi-centre, split-face study of photodynamic therapy with Metvix 160 mg/g cream in subjects with acne vulgaris.
    Medical condition: Moderate inflammatory acne vulgaris.
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004627-38 Sponsor Protocol Number: ASF-1057-301 Start Date*: 2007-11-12
    Sponsor Name:Astion Pharma A/S
    Full Title: Efficacy and safety of ASF 1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, double-blind, vehicle- and placebo controlled, parallel groups, multi-centre trial
    Medical condition: Seborrhoeic dermatitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) DK (Completed) FR (Completed) FI (Completed) GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003807-39 Sponsor Protocol Number: 310603BS Start Date*: 2011-10-04
    Sponsor Name:GALENpharma
    Full Title: A phase II, single-center, randomized, observer-blind, vehicle-controlled trial to determine clinical equivalence of MomeGalen Cream (mometasone furoate 0.1 %) to Ecural® Fettcreme (reference drug)...
    Medical condition: Subjects with a stable phase of chronic psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    14.0 10040785 - Skin and subcutaneous tissue disorders 10050576 Psoriasis vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 19 09:00:55 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA